Spots Global Cancer Trial Database for Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCC
Official Title: Multicenter Randomized Controlled Trial of Adenovirus-mediated Adjuvant Gene Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma
Study ID: NCT03313596
Conditions
Study Description
Brief Summary: Compare the effect of liver transplantation (LT) plus ADV-TK gene therapy versus LT only in advanced primary hepatocellular carcinoma.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Beijing Youan Hospital, Beijing, Beijing, China
301 Military Hospital, Beijing, , China
General Hospital of Chinese People's Armed Police, Beijing, , China
The Third XiangYa Hospital of Central South University, Changsha, , China
West China Hospital of Sichuan University, Chengdu, , China
The Third Affiliated Hospital,Sun Yat-sen University, Guangzhou, , China
The First Affiliated Hospital, Zhejiang University, Hangzhou, , China
Zhongshan Hospital of Fudan University, Shanghai, , China
The First Affiliated Hospital of China Medical University, Shenyang, , China
The First Center Hospital of Tianjin, Tianjin, , China
The First Hospital of Xinjiang Medical University, Urumqi, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
